SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
76 hedge funds and large institutions have $134M invested in scPharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 29
24% less capital invested
Capital invested by funds: $177M → $134M (-$42.4M)
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
Holders
76
Holding in Top 10
2
Calls
$753K
Puts
$157K
Top Buyers
| 1 | +$2.24M | |
| 2 | +$2.2M | |
| 3 | +$1.42M | |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1M |
| 5 |
Renaissance Technologies
New York
|
+$975K |
Top Sellers
| 1 | -$3.86M | |
| 2 | -$3.56M | |
| 3 | -$3.13M | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$1.44M |
| 5 |
Walleye Capital
New York
|
-$1.42M |